全文获取类型
收费全文 | 1007篇 |
免费 | 48篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 66篇 |
妇产科学 | 38篇 |
基础医学 | 94篇 |
口腔科学 | 29篇 |
临床医学 | 76篇 |
内科学 | 223篇 |
皮肤病学 | 39篇 |
神经病学 | 54篇 |
特种医学 | 17篇 |
外科学 | 273篇 |
综合类 | 13篇 |
预防医学 | 21篇 |
眼科学 | 33篇 |
药学 | 29篇 |
中国医学 | 1篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 2篇 |
2023年 | 11篇 |
2022年 | 17篇 |
2021年 | 37篇 |
2020年 | 25篇 |
2019年 | 26篇 |
2018年 | 29篇 |
2017年 | 23篇 |
2016年 | 38篇 |
2015年 | 44篇 |
2014年 | 38篇 |
2013年 | 51篇 |
2012年 | 70篇 |
2011年 | 62篇 |
2010年 | 31篇 |
2009年 | 40篇 |
2008年 | 74篇 |
2007年 | 84篇 |
2006年 | 64篇 |
2005年 | 54篇 |
2004年 | 57篇 |
2003年 | 26篇 |
2002年 | 39篇 |
2001年 | 33篇 |
2000年 | 39篇 |
1999年 | 10篇 |
1998年 | 10篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1994年 | 4篇 |
1993年 | 1篇 |
1992年 | 4篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1980年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有1063条查询结果,搜索用时 15 毫秒
101.
Karasu Z Akyildiz M Kilic M Zeytunlu M Aydin U Tekin F Yilmaz F Ozacar T Akarca U Ersoz G Gunsar F Ilter T Lucey MR 《Journal of gastroenterology and hepatology》2007,22(12):2124-2129
BACKGROUND AND AIM: Living donor liver transplantation (LDLT) has particular advantages for Turkey where hepatitis B virus (HBV) infection is the most common cause of cirrhosis, both because LDLT circumvents the difficulties encountered in the emerging world in providing deceased donor organs, and because it allows preemptive antiviral therapy. The aim of this study was to review one institution's experience with LDLT in patients with chronic HBV infection. METHODS: A total of 109 patients with chronic HBV infection underwent LDLT between September 1999 and June 2005, of whom 40 were coinfected with hepatitis D virus and 23 had hepatocellular carcinoma. Antiviral prophylaxis was attempted in all, beginning prior to transplantation with lamivudine or adefovir, and continuing after transplantation with low dose intramuscular hyperimmune B immunoglobulin (HBIg) plus lamivudine or adefovir. RESULTS: In a median follow up of 20 months (range 1-66 months), there was no donor mortality. One-year recipient survival was 90%, and in total 16 recipients died. None of the deaths was related to HBV. Recurrence of HBV infection was detected by reappearance of serum hepatitis B surface antigen in six patients (5.5%) at 5, 8, 12, 17, 34 and 46 months after transplantation, respectively. There was no influence of donor hepatitis B core antibody status on the likelihood of recurrence of HBV in the allograft. CONCLUSION: The results indicate that LDLT with antiviral treatment and low dose HBIg provides excellent results for donors and recipients. 相似文献
102.
Aytekin FO Teke Z Aydin C Kabay B Yenisey C Sacar S Demir EM Tekin K 《American journal of surgery》2007,193(6):723-729
BACKGROUND: Tempol (Sigma-Aldrich, Steinheim, Germany) is a stable piperidine nitroxide of low molecular weight that permeates biologic membranes and scavenges superoxide anions in vitro. In recent animal studies, the delaying effect of intraperitoneal sepsis on the healing of colonic anastomoses has been shown. In this study we aimed to investigate the effects of Tempol on the healing of colonic anastomoses in the presence of polymicrobial sepsis. METHODS: Anastomosis of the left colon was performed on the day after cecal ligation and puncture (CLP) in 30 rats that were divided into 3 groups: sham-operated control (laparotomy and cecal mobilization, group I, n = 10), CLP (group II, n = 10), Tempol-treated group (30 mg/kg intravenously before the construction of colonic anastomosis, group III, n = 10). On postoperative day 6, all animals were killed and anastomotic bursting pressures were measured in vivo. Tissue samples were obtained for further investigation of anastomotic hydroxyproline (HP) contents, perianastomotic myeloperoxidase (MPO) activity, malondialdehyde (MDA), and glutathione (GSH) levels. RESULTS: There was a statistically significant increase in MPO activity and MDA levels in the CLP group (group II), along with a decrease in GSH levels, anastomotic HP contents, and bursting pressure values when compared with controls (group I). However, Tempol treatment led to a statistically significant increase in anastomotic bursting pressure values, tissue HP contents, and GSH levels, along with a decrease in MPO activity and MDA levels in group III (P < .05). CONCLUSIONS: This study showed that Tempol treatment significantly prevented the delaying effect of CLP-induced polymicrobial sepsis on anastomotic healing in the left colon. Further clinical studies are needed to clarify whether Tempol may be a useful therapeutic agent to increase the safety of the anastomosis during particular surgeries in which sepsis-induced organ injury occurs. 相似文献
103.
104.
Haider HH Nishida S Selvaggi G Levi D Tekin A Moon JI Tzakis AG 《Clinical transplantation》2008,22(5):664-667
A technically difficult liver transplant was performed in a 68-yr-old male with Alveolar Echinococcosis causing end-stage liver disease. The pathology was extensive and included hepatic artery thrombosis, Budd-Chiari syndrome, and right hemidiaphragm invasion necessitating resection of this portion of diaphragm and direct donor cava anastomosis to the right atrium. The patient is now 21 months since transplant disease free with normal liver function. 相似文献
105.
Toprak O Ersoy R Uzum A Memis A Cirit M Akpolat T 《The American journal of the medical sciences》2007,334(5):396-398
Behcet's disease (BD) is a rare multisystem inflammatory disorder characterized by recurrent ulcers affecting the mouth and genitals, various skin lesions, relapsing iritis, and vasculitis. Vascular events may dominate the clinical presentation in some patients with BD. Hitherto three forms of vascular disease such as venous occlusions, arterial aneurysms, and arterial occlusions have been reported in BD. Renal vascular involvement has reported in less than 1% of the patients with vascular BD. A case of BD with renovascular hypertension is reported. To our knowledge, a case of BD with renovascular hypertension treated with angioplasty and stent implantation has not been reported previously. 相似文献
106.
107.
Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer 总被引:1,自引:0,他引:1
Yamac D Ozturk B Coskun U Tekin E Sancak B Yildiz R Atalay C 《Advances in therapy》2008,25(8):801-809
INTRODUCTION: YKL-40 is a growth factor for connective tissue cells; it also stimulates the migration of endothelial cells. YKL-40 is secreted by cancer cells, and elevated serum levels have been associated with poorer prognosis in metastatic breast cancer. In the present study we evaluated the prognostic role of serum YKL-40 levels in patients with locally advanced breast cancer. METHODS: YKL-40 levels were measured using ELISA in serum samples obtained from 45 breast cancer patients prior to surgery and chemotherapy. The median follow-up time was 46 months (range, 10-96 months). All patients underwent surgery after chemotherapy. During the follow-up period, 21 patients relapsed and there were 17 deaths. RESULTS: The median serum YKL-40 concentration in patients with locally advanced breast cancer was 149.5 mug/l (range, 25.0-1021.3 mug/l). This was higher than levels observed in healthy female controls but the difference was not significant (P=0.44). Serum YKL-40 levels were also higher in patients with tumour size >2 cm and node-positive disease but again the differences were not significant (P>0.05). Tumour volume was correlated with serum YKL-40 levels (r=0.308, P=0.039). High serum YKL-40 levels were associated with shorter disease-free and overall survival although this trend failed to reach significance (P>0.05). Multivariate analysis including tumour size, lymph node status, oestrogen and progesterone receptor status, tumour grade, and serum YKL-40 levels indicated that serum YKL-40 levels were an independent prognostic variable for overall survival (hazard ratio, 1.004; 95% confidence intervals: 1.00, 1.07; P=0.027). Tumour size, lymph node status and oestrogen receptor status were also independent prognostic variables for overall survival (P<0.05). CONCLUSION: Our results show that serum levels of the growth factor YKL-40 may be a useful prognostic indicator of outcome for patients with locally advanced breast cancer. Further studies are required to fully elucidate the biological function of YKL-40 in breast cancer. 相似文献
108.
Dirim A Haberal AN Goren MR Tekin MI Peskircioglu L Demirhan B Ozkardes H 《International urology and nephrology》2008,40(4):861-868
Objective To evaluate the prognostic value of new markers such as VEGF (vascular endothelial growth factor), COX-2 (cyclooxygenase-2),
and PCNA (proliferating cell nuclear antigen) and review their differences in expression by histological subtype in patients
with renal cell carcinoma (RCC).
Methods About 99 patients who underwent radical (n = 79) or partial nephrectomy (n = 20) were included in this study. Histopathological specimens from the subjects were retrospectively analyzed immunohistochemically
for the presence of VEGF, COX-2, or PCNA.
Results Mean staining ratios for VEGF, COX-2, and PCNA were 16.5, 16.8, and 31%, respectively. Correlations were evaluated among these
three prognostic factors. There was no correlation between PCNA and VEGF (P = .068), but there were significant correlations between COX-2 and both PCNA and VEGF (P = .005 and P = .000, respectively). A significant correlation was found between the expression of VEGF and both pathologic stage and vascular
invasion (P = .018 and P = .025, respectively). In addition, patients with conventional RCC had significantly lower VEGF and COX-2 levels than those
with papillary RCC (P < .012).
Conclusions It is obvious that prognostic factors such as VEGF, COX-2, and PCNA may vary depending on histological subtype. The level
of expression of these factors together with histological subtype may provide valuable predictive information about the outcome
of treatment. 相似文献
109.
Teke Z Aytekin FO Kabay B Yenisey C Aydin C Tekin K Sacar M Ozden A 《World journal of surgery》2007,31(9):1835-1842
Background Pyrrolidine dithiocarbamate (PDTC) is a low-molecular-weight thiol antioxidant and potent inhibitor of nuclear factor-κB (NF-κB)
activation. It has been shown to attenuate local harmful effects of ischemia/reperfusion (I/R) injury in many organs. In recent
animal studies, a delaying effect of remote organ I/R injury on the healing of colonic anastomoses has been demonstrated.
In this study we investigated whether PDTC prevents harmful systemic effects of superior mesenteric I/R on left colonic anastomosis
in rats.
Methods Anastomosis of the left colon was performed in 40 rats randomly allocated into the following four groups: (1) Sham-operated
group (group I, n = 10)—simultaneously with colonic anastomosis, the superior mesenteric artery and collateral branches divided from the celiac
axis and the inferior mesenteric artery were isolated but not occluded. (2) Sham+PDTC group (group II, n = 10)—identical to sham-operated rats except for the administration of PDTC (100 mg/kg IV bolus) 30 minutes prior to commencing
the experimental period. (3) I/R group (group III, n = 10)—60 minutes of intestinal I/R by superior mesenteric artery occlusion. (4) PDTC-treated group (group IV, n = 10)—PDTC 100 mg/kg before and after the I/R. On postoperative day 6, all animals were sacrificed, and anastomotic bursting
pressures were measured in vivo. Tissue samples were obtained for investigation of anastomotic hydroxyproline (HP) contents,
perianastomotic malondialdehyde (MDA) levels, myeloperoxidase activity (MPO), and glutathione (GSH) level.
Results There was a statistically significant decrease in anastomotic bursting pressure values, tissue HP content and GSH level, along
with an increase in MDA level and MPO activity in group III, when compared to groups I, II, and IV (p < 0.05). However, PDTC treatment led to a statistically significant increase in anastomotic bursting pressure values, tissue
HP content and GSH level, along with a decrease in MDA level and MPO activity in group IV (p < 0.05).
Conclusions This study showed that PDTC treatment significantly prevented the delaying effect of remote organ I/R injury on anastomotic
healing in the colon. Further clinical studies are needed to clarify whether PDTC may be a useful therapeutic agent for increasing
the safety of the anastomosis during particular operations where remote organ I/R injury occurs. 相似文献
110.
Dinckan A Tekin A Turkyilmaz S Kocak H Gurkan A Erdogan O Tuncer M Demirbas A Malek-Hosseini SA 《Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation》2007,5(2):716-719
Owing to the limited donor pool at transplant centers, grafts may be taken from marginal donors with congenital abnormalities, one of the most common of which is a fusion abnormality. Horseshoe kidneys may be transplanted to a single recipient en bloc or to 2 recipients after division. In our clinic, 3 grafts (1 obtained from a living donor and 2 from a deceased donor) were successfully transplanted to 3 patients. In select patients, horseshoe kidneys may be used for transplant. 相似文献